Literature DB >> 22403780

Atypical diffusion-restricted lesion in 5-Fluorouracil encephalopathy.

W-W Lee1, J-S Kim, K R Son, H-M Kwon.   

Abstract

Central nervous system toxicity of 5-FU could show various manifestations, such as decreased alertness, disorientation, and agitation. It is generally accepted that lesions of 5-FU encephalopathy are mainly in the deep cerebral white matter and corpus callosum on MR imaging. Here we describe a case of 5-FU encephalopathy in gastric cancer with an atypical reversible diffusion-restricted lesion on MR imaging, showing bilateral basal ganglia, thalami, and parasagittal frontal cortex involvement on diffusion and T2-weighted imaging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22403780      PMCID: PMC7965488          DOI: 10.3174/ajnr.A2781

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  7 in total

Review 1.  Hyperammonemic encephalopathy.

Authors:  Saul W Brusilow
Journal:  Medicine (Baltimore)       Date:  2002-05       Impact factor: 1.889

2.  Reversible MRI and CT findings in uremic encephalopathy.

Authors:  J Okada; K Yoshikawa; H Matsuo; K Kanno; M Oouchi
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

3.  Reversible findings of restricted diffusion in 5-fluorouracil neurotoxicity.

Authors:  L T Lucato; A M McKinney; J Short; M Teksam; C L Truwit
Journal:  Australas Radiol       Date:  2006-08

4.  Capecitabine-induced multifocal leukoencephalopathy: a report of five cases.

Authors:  A Videnovic; I Semenov; R Chua-Adajar; L Baddi; D T Blumenthal; A C Beck; T Simuni; S Futterer; W Gradishar; C Tellez; J J Raizer
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

Review 5.  Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil.

Authors:  André B P van Kuilenburg
Journal:  Eur J Cancer       Date:  2004-05       Impact factor: 9.162

Review 6.  Central and peripheral nervous system toxicity of common chemotherapeutic agents.

Authors:  Chrissa Sioka; Athanassios P Kyritsis
Journal:  Cancer Chemother Pharmacol       Date:  2008-11-25       Impact factor: 3.333

7.  Chemotherapy related encephalopathy in a patient with Stage IV cervical carcinoma treated with cisplatin and 5-fluorouracil: a case report.

Authors:  Amy L Chue; Indrajit N Fernando; Syed A Hussain; David A Yates
Journal:  Cases J       Date:  2009-07-30
  7 in total
  2 in total

1.  5-FU-induced leukoencephalopathy with reversible lesion of splenium of corpus callosum in a patient with colorectal cancer.

Authors:  Gyanendra Acharya; Maria T Cruz Carreras; Terry Wynne Rice
Journal:  BMJ Case Rep       Date:  2017-11-21

2.  Diagnosis and management of 5-fluorouracil (5-FU)-induced acute leukoencephalopathy: lessons learnt from a single-Centre case series.

Authors:  Neethu Jose; Anjana Joel; Rajesh Joseph Selvakumar; Jebakarunya Ramireddy; Ajoy Oommen John; Josh Thomas Georgy; Ashish Singh; Thomas Samuel Ram
Journal:  J Egypt Natl Canc Inst       Date:  2022-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.